"...More research is needed into how GDNF works in the body, but the data presented by Mwangi et al. suggest that it may cause increased calorie burn in both brown and white fat cells and in muscle tissue. Their research also suggests that GDNF and its receptors may be unique and effective targets for obesity prevention and treatment therapies..."

http://www.newswise.com/articles/a-p...multimedia%5D=

(can only hope this is true. A diet pharmaceutical product will receive a lot more interest than a product for the PD market. Perhaps the research will be able to be used for PD)

This is exciting news! I also hope this interest in GDNF research as it relates to obesity will speed up GDNF research for PD.